n-3 Polyunsaturated fatty acids and trans fatty acids in patients with the metabolic syndrome: A case-control study in Korea

British Journal of Nutrition

Volumn 100, Issue 3, 2008, Pages 609-614

  Lee, Eunjeong ^a   Lee, Sangyeoup ^b   Park, Yongsoon ^a  

^a Hanyang University   (South Korea)

^b Pusan National University   (South Korea)

Author keywords

Metabolic syndrome; Omega 3 index; Trans fatty acid

Indexed keywords

C REACTIVE PROTEIN; DOCOSAHEXAENOIC ACID; ICOSAPENTAENOIC ACID; INSULIN; OMEGA 3 FATTY ACID; TRANS FATTY ACID;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEMALE; HUMAN; INSULIN BLOOD LEVEL; KOREA; MALE; METABOLIC SYNDROME X; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION RESEARCH; PREDICTION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX RATIO; WAIST CIRCUMFERENCE;

BLOOD GLUCOSE; BODY MASS INDEX; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; ERYTHROCYTES; FATTY ACIDS, OMEGA-3; FEMALE; HUMANS; INSULIN; KOREA; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; REGRESSION ANALYSIS; RISK; TRANS FATTY ACIDS; WAIST CIRCUMFERENCE;

EID: 49649121573     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114508925435     Document Type: Article

References (40)

1. National Cholesterol Education Program (2001) Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA 295, 2486-2497.
2. Grundy SM, Cleeman JL, Daniels SR, et al. (2005) Diagnosis and management of the metabolic syndrome: An American Heart Association/ National Heart, Lung, and Blood Institute Scientific Statement. Circulation 112, 2735-2752.
3. Ford ES, Giles WS & Dietz WH (2002) Prevalence of the metabolic syndromes among US adults: Findings from the Third National Health and Nutrition Examination Survey. JAMA 297, 356-359.
4. Oh JY, Hong YS & Sung YA (2004) Prevalence and factor analysis of metabolic syndromes in urban Korean population. Diabetes Care 27, 2027-2032.
5. Wang L, Folsom AF, Zheng ZJ, Pankow JS & Eckfeldt JH (2003) Plasma fatty acid composition and incidence of diabetes in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Clin Nutr 78, 91-98.
6. Wang L, Folsom AR & Eckfeldt JH (2003) Plasma fatty acid composition and incidence of coronary heart disease in middle-aged adults: The Atherosclerosis Risk in Communities (ARIC) Study. Nutr Metab Cardiovasc Dis 13, 256-266.
7. Tremblay AJ, Despres JP, Piche ME, et al. (2004) Associations between the fatty acid content of triglyceride, visceral adipose tissue accumulation, and components of the insulin resistance syndrome. Metabolism 53, 310-317.
8. Mori TA, Burke V, Puddey IB, et al. (2000) Purified eicosapentaenoic and docosahexaenoic acids have differential effects on serum lipids and lipoproteins, LDL particle size, glucose, and insulin in mildly hyperhpidemic men. Am J Clin Nutr 71, 1085-1094.
9. Holness MJ, Greenwood G, Smith N & Sugden M (2003) Diabetogenic impact of long chain omega-3 acids on pancreatic beta-cell function and the regulation of endogenous glucose production. Endocrinology 144 3958-3968.
10. Prisco D, Paniccia R, Bandinelli B, et al. (1998) Effect of medium-term supplementation with a moderate dose of n-3 polyunsaturated fatty acids on blood pressure in mild hypertensive patients. Thromb Res 91, 103-112.
11. Harris WS, Park YS & Isley WL (2003) Cardiovascular disease and long-chain omega-3 fatty acids. Curr Opin Lipidol 14, 9-14.
12. Troisi R, Willett WC & Weiss ST (1992) Trans-fatty acid intake in relation to serum lipid concentrations in adult men. Am J Clin Nutr 56, 1019-1024.
13. Mensink RP, Zock PL, Kesler AD & Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146-1155.
14. Nestel P, Noakes M, Belling B, et al. (1992) Plasma lipoprotein lipid and Lp[a] changes with substitution of elaidic acid for oleic acid in the diet. J Lipid Res 33, 1029-1036.
15. Katan MB, Zock PL & Mensink RP (1995) Trans fatty acids and their effects on hpoproteins in humans. Annu Rev Nutr 15, 473-493.
16. Hu FB, Manson JE, Stampfer MJ, et al. (2001) Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 345 790-797.
17. Lopez-Garcia E, Schulze MB, Meigs JB, et al. (2005) Consumption of trans fatty acids is related to plasma biomarkers of inflammation and eadothelial dysfunction. J Nutr 135, 562-566.
18. Mozaffarian D, Katan MB, Ascherio A, Stampfer MJ & Willett WC (2006) Trans fatty acids and cardiovascular disease. N Engl J Med 354 1601-1613.
19. Nogi A, Yang J, Li L, Yamasaki M, Watanabe M, Hashimoto M & Shiwaku K (2007) Plasma n-3 polyunsaturated fatty acid and cardiovascular disease risk factors in Japanese, Korean and Mongolian workers. J Occup Health 49, 205-216.
20. Harris WS & Von Schacky C (2004) The omega-3 index: A new risk factor for death from coronary heart disease? Prev Med 39, 212-220.
21. Friedwald WT, Levy RI & Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18, 499-502.
22. Matthews DR, Hosker JP, Rudenski AS, et al. (2003) Impact of glucose intolerance and insulin resistance on cardiac structure and function: Sex-related differences in the Framingham Heart Study. Circulation 107, 448-454.
23. Sun Q, Ma J, Campos H, Hankinson SE, et al. (2007) A prospective study of trans fatty acids in erythrocytes and risk of coronary heart disease. Circulation 115, 1858-1865.
24. Salmeron J, Hu FB, Manson JE, et al. (2001) Dietary fat intake and risk of type 2 diabetes in women. Am J Clin Nutr 73, 1019-1022.
25. Koh-Banerijee P, Chu N, Spiegelman D, Rosner B, Colditz G Willett W & Rim E (2003) Prospective study of the association of changes in dietary intake, physical activity, alcohol consumption, and smoking with 9-y gain in waist circumference among 16587 US men. Am J Clin Nutr 78, 719-727.
26. Kavanagh K, Jones KL, Sawyer J, Kelley K, Carr JJ, Wagner JD & Rudel LL (2007) Trans fat diet induces abdominal obesity and changes in insulin sensitivity in monkeys. Obesity 15, 1675-1684.
27. Hunter JE (2006) Dietary trans fatty acids: Review of recent human studies and food industry response. Lipids 41, 967-992.
28. Dyerberg J, Eskesen DC, Andersen PW, et al. (2004) Effects of trans- and n-3 unsaturated fatty acids on cardiovascular risk markers in healthy males. An 8 weeks dietary intervention study. Eur J Clin Nutr 58, 1062-1070.
29. Karabulut I (2007) Fatty acid composition of frequently consumed foods in Turkey with special emphasis on trans fatty acids. Int J Food Sci Nutr 1, 1-10.
30. Baylin A, Siles X, Donovan-Palmer A, Fernandez X & Campos H (2007) Fatty acid composition of Costa Rican foods including trans fatty acid content. J Food Comp Analysis 20, 182-192.
31. Clarke SD (2000) Polyunsaturated fatty acid regulation of gene transcription: A mechanism to improve energy balance and insulin resistance. Br J Nutr 8, S59-S66.
32. Clarke SD (2001) Polyunsaturated fatty acid regulation of gene transcription a molecular mechanism to improve the metabolic syndrome. J Nutr 131, 1129-1131
33. Tai ES, Corella D, Demissie S, et al. (2005) Polyunsaturated fatty acids interact with the PPARA-L162V polymorphism to affect plasma triglyceride and apolipoprotein C-III concentrations in the Framingham Heart Study. J Nutr 135, 397-403.
34. Warensjö E, Sundström J, Lind L & Vessby B (2006) Factor analysis of fatty acids in serum lipids as a measure of dietary fat quality in relation to the metabolic syndrome in men. Am J Clin Nutr 84 442-448.
35. Klein-Platat C, Drai J, Oujaa M, Schlienger JL & Simon C (2005) Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 82, 1178-1184.
36. Sands SA, Reid KJ, Windsor SL & Harris WS (2005) The impact of age, body mass index, and fish intake on the EPA and DHA content of human erythrocytes. Lipids 40, 343-347.
37. Mozaffarian D, Bryson CL, Lemaitre RN, et al. (2005) Fish intake and risk of incident heart failure. J Am Coll Cardiol 45, 2015-2021.
38. Kris-Etherton PM, Harris WS, Appel LJ & American Heart Association Nutrition Committee (2002) Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation 106, 2747-2757.
39. Albert CM, Campos H, Stampfer MJ, et al. (2002) Blood levels of long-chain n-3 fatty acids and the risk of sudden death. N Engl J Med 346, 1113-1118.
40. GISSI-Prevenzione Investigators (1999) Dietary supplementation with n 3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarrtion: Results of the GISSI-Prevenzione trial. Lancet 354, 447-455.